NEW YORK, May 12, 2014 (GLOBE NEWSWIRE) -- New York- based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Laidlaw & Company (UK) Ltd. as sole Placement …
Sichenzia Ross Friedman Ference LLP Advises AV Therapeutics, Inc. on $1.26 million PIPE Offering
NEW YORK, April 30, 2014 (GLOBE NEWSWIRE) -- New York based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented AV Therapeutics, Inc. (OTCQB:AVTH) on a $1.26 …
Sichenzia Ross Friedman Ference LLP Advises J.P. Turner & Company, L.L.C on $ 2.5 million Private Placement of X2 Bio Systems, Inc..
NEW YORK, April 18, 2014 (GLOBE NEWSWIRE) -- New York- based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented J.P. Turner & Company as sole Placement …
Sichenzia Ross Friedman Ference LLP Advises Brean Capital LLC on $ 6.5 million Registered Direct Offering of ClearSign Combustion Corporation
NEW YORK, March 5, 2014 (GLOBE NEWSWIRE) -- New York- based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Brean Capital LLC. as sole Placement Agent in a …
Sichenzia Ross Friedman Ference LLP Represents Tonix Pharmaceuticals in $43.5 Million Shelf Takedown
SRFF Named-Partner, Marc J. Ross, Leads Transaction Whose Proceeds Will fund Development of Medications for the Treatment of Fibromyalgia and Post-Traumatic Stress Disorder NEW YORK CITY – February …
Sichenzia Ross Friedman Ference LLP Advises Xenetic Biosciences in Reverse Merger and Direct PIPE Investment.
SRFF Team Led by Named-Partner, Marc J. Ross, Succeeds in Leveraging Unique Solution and Direct PIPE Investment Totaling $10 million NEW YORK CITY – February 12, 2014. Sichenzia Ross Friedman …
